17 studies were found.

1.		Recruiting	Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain Conditions: adult glioblastoma; Stage IV Melanoma; brain metastases; adult giant cell glioblastoma; adult gliosarcoma
2.		Recruiting	Boron Neutron Capture Therapy in Treating Patients With Melanoma Conditions: Recurrent Melanoma; stage 0 melanoma; stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
3.		No longer recruiting	Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma Conditions: stage III melanoma; Recurrent Melanoma
4.		No longer recruiting	Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer Condition: stage IV breast cancer
5.		No longer recruiting	Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors Conditions: stage III endometrial cancer; peritoneal cavity cancer; endometrial adenocarcinoma; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
6.		No longer recruiting	Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer
7.		Suspended	Gene Therapy in Treating Patients With Cancer Conditions: Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
8.		Completed	Interleukin-12 in Treating Patients With Advanced Cancer Condition: unspecified adult solid tumor, protocol specific
9.		No longer recruiting	Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation Conditions: stage IV breast cancer; recurrent breast cancer
10.		No longer recruiting	Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
11.		No longer recruiting	Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma Conditions: recurrent adult Hodgkin's lymphoma; recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
12.		Recruiting	Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma Conditions: recurrent adult Hodgkin's lymphoma; anaplastic large cell lymphoma
13.		Recruiting	Progesterone vs Placebo Therapy for Women with Epilepsy Condition: Epilepsy
14.		Recruiting	Study of Recombinant Human Insulin-Like Growth Factor I in Patients with Severe Insulin Resistance Conditions: Insulin Resistance; Hyperglycemia
15.		No longer recruiting	Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Condition: adult non-Hodgkin's lymphoma
16.		Recruiting	Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
17.		Recruiting	Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma